How to find the best strategy for you ?
Value
Our factor investing score meticulously assesses the intrinsic value of each asset, providing invaluable insights into its potential for long-term growth.
Growth
With a keen focus on growth prospects, our factor investing score analyzes each asset's trajectory, offering strategic guidance for maximizing returns in dynamic market conditions..
Quality
With an emphasis on quality metrics, our factor investing score meticulously evaluates the fundamental strength and stability of each asset, safeguarding your portfolio against potential risks.
Volatility
By meticulously evaluating volatility, our factor investing score helps you navigate market turbulence, ensuring a balanced portfolio resilient to unpredictable fluctuations.
Momentum
Leveraging momentum analysis, our factor investing score identifies assets poised for upward trends, empowering you to capitalize on market momentum for optimized performance.
Yield
Focused on yield optimization, our factor investing score identifies assets with attractive income potential, enabling you to construct a diversified portfolio tailored to your income objectives.
Create a reliable strategy with the A-Score
Undervalued company with stable and reliable business like Warren Buffet
Get detailled Investment Case for more than 5500 Stocks
Strong Company Updates
Get a complete corporate access : reliable, clear, and always available at the time you need it
Fraport(FRA.DE): Frankfurt Airport Q1: Jet Fuel Jitters, Ground Gains, and a Cautious Outlook
Frankfurt Airport’s first‑quarter results showed revenues of €1.18 bn, up 3% year‑on‑year, and an operating margin of 12%, reflecting steady passenger traffic amid volatile jet‑fuel markets. Earnings per share fell to –€0.19 versus the consensus estimate of –€0.25, underscoring the cost impact of a 200% rise in fuel prices. As CFO Zieschang noted, “we are looking forward based on the assumption that there is always an availability of jet fuel,” a caveat that highlights the company’s cautious stance on forward‑looking guidance. The valuation snapshot shows a P/E of 14.88, a P/B of 1.23, a P/S of 1.44, and an EV/EBITDA of 10.59, with a free‑cash‑flow yield of 5.19% and an ROIC of 3.26%.
May -11
Compass Group(CPG.L): None
None
May -11
Halozyme Therapeutics(HALO): None
None
May -11
Quality Equity Research. Easy Access
Get started with our cost-effective equity research
Monthly
Annual Up to 30% Discount
Free Trial
FREE
7 Days- Unlimited access to Watchlist
- Unlimited access to screener
- Unlimited access to AI Assistant
- Access to US Investment Case
- API calls limited to 10/day
- Request new coverage
- Premium Support
Premium
$39.99
per month
- Unlimited access to Watchlist
- Unlimited access to screener
- Unlimited access to AI Assistant
- Unlimited access to Investment Case
- API calls limited to 250/day
- Request new coverage
- Premium Support
Ultimate
$99.90
- Unlimited access to Watchlist
- Unlimited access to screener
- Unlimited access to AI Assistant
- Unlimited access to Investment Case
- API calls limited to 2500/minute
- Request new coverage
- Premium Support
